Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4(+) T Cells

Antiretroviral therapy can reduce human immunodeficiency virus type 1 (HIV-1) viremia to below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However, latent HIV-1 persists in resting CD4(+) T cells, and low residual levels of free virus are found in the plasma. L...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Bailey, Justin R., Sedaghat, Ahmad R., Kieffer, Tara, Brennan, Timothy, Lee, Patricia K., Wind-Rotolo, Megan, Haggerty, Christine M., Kamireddi, Ashrit R., Liu, Yi, Lee, Jessica, Persaud, Deborah, Gallant, Joel E., Cofrancesco, Joseph, Quinn, Thomas C., Wilke, Claus O., Ray, Stuart C., Siliciano, Janet D., Nettles, Richard E., Siliciano, Robert F.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2006
الموضوعات:
Pathogenesis and Immunity
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC1488985/
https://ncbi.nlm.nih.gov/pubmed/16775332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00591-06
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة